AIM ImmunoTech (AIM) Income Statement

Click line-items for a historical chart and %

Sales, net	7.11M
Cost of sales	4.64M
Gross profit	2.47M
Selling, general and administrative expenses	3.09M
Operating (loss) income	-629K
Interest expense, net	-31K
Gain from casualty
Other expense	4K
Loss on extinguishment of debt
Total Nonoperating Income (Expense)	-27K
(Loss) income before income taxes	-656K
Income tax benefit (provision)	243K
Net (loss) income	-413K
Basic (loss) earnings per share (in dollars per share)	-0.11
Diluted (loss) earnings per share (in dollars per share)	-0.11
Weighted average shares outstanding basic (in shares)	3.84M
Weighted average shares outstanding diluted (in shares)	3.84M

Entities mentioned with aim

View All Entities